Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Early phase 1Not yet taking people in ChinaCD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's Lymphoma
- Where
- Hangzhou
- People
- 72
- Run by
- Zhejiang University
See details and how to joinNCT04609241 - Early phase 1Not yet taking people in ChinaIL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia
- Where
- Hangzhou
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT04599543 - Early phase 1Taking peopleA Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
- Where
- Hangzhou
- Age
- 3 years to 70 years
- People
- 100
- Run by
- He Huang
See details and how to joinNCT04283006 - No phaseTaking peopleDesign and Implementation of the Pediatric Liver Transplantation Biobank
- Where
- Chongqing
- Age
- 1 month to 18 years
- People
- 500
- Run by
- Children's Hospital of Chongqing Medical University
See details and how to joinNCT04477967 - No phaseTaking peopleModality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer
- Where
- Beijing
- People
- 654
- Run by
- Peking University People's Hospital
See details and how to joinNCT04453904 - Phase 4Not yet taking people in ChinaCombination Therapy of Anthracyclines for Children With Nephroblastoma
- Where
- Shenyang
- Age
- 6 months to 14 years
- People
- 120
- Run by
- Shengjing Hospital
See details and how to joinNCT03892330 - No phaseNot yet taking people in ChinaEndoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer
- Where
- Beijing
- People
- 300
- Run by
- Peking University Third Hospital
See details and how to joinNCT03857737 - Phase 3Taking peopleSalvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
- Where
- Beijing
- Age
- 16 years to 70 years
- People
- 300
- Run by
- Chinese Academy of Medical Sciences
See details and how to joinNCT03731442 - Phase 1/2Taking peopleCD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas
- Where
- Beijing
- Age
- 16 years to 80 years
- People
- 30
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT02259556